Related references
Note: Only part of the references are listed.Understanding of molecular mechanisms in natural killer cell therapy
Suk Ran Yoon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy
Min Lu et al.
FEBS LETTERS (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo
C. A. Merkel et al.
CANCER GENE THERAPY (2013)
IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
Jeffrey L. Wong et al.
CANCER RESEARCH (2013)
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Alexandre Iannello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L. Kaufman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Timing and Magnitude of Type I Interferon Responses by Distinct Sensors Impact CD8 T Cell Exhaustion and Chronic Viral Infection
Yaming Wang et al.
CELL HOST & MICROBE (2012)
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
Oliver Kepp et al.
CANCER AND METASTASIS REVIEWS (2011)
Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
Sonja Textor et al.
CANCER RESEARCH (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies
Luiz Rodrigues et al.
EXPERT REVIEW OF VACCINES (2009)
Development of an adenoviral vector with robust expression driven by p53
Marcio C. Bajgelman et al.
VIROLOGY (2008)
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15
Claire L. Sutherland et al.
BLOOD (2006)
Melanocyte transformation associated with substrate adhesion impediment
Sueli M. Oba-Shinjo et al.
NEOPLASIA (2006)
Divorcing ARF and p53: an unsettled case
Charles J. Sherr
NATURE REVIEWS CANCER (2006)
Natural killer cells activated by MHC class Ilow targets prime dendritic cells to induce protective CD8 T cell responses
R Mocikat et al.
IMMUNITY (2003)
Reciprocal activating interaction between natural killer cells and dendritic cells
F Gerosa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Quantifying the relationship between multiple immunological parameters and host resistance: Probing the limits of reductionism
D Keil et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
